" class="no-js "lang="en-US"> BRIM Biotechnology Archives - Medtech Alert
Friday, June 21, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

BRIM Plans to launch a New Funding Round to Accelerate Late-Stage Clinical Trial and Initiate a New Phase 2 Trial for Orphan Drug BRM424

BRIM Biotechnology, a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint […]

BRIM Biotechnology Announces First Patient Enrollment in Pivotal Phase 3 Clinical Trial of BRM421 for Dry Eye Disease

BRIM Biotechnology, a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more